| mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
0.0032 |
0.9 |
| mRNA |
blebbistatin |
CTRPv2 |
pan-cancer |
AAC |
-0.006 |
0.9 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
| mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
| mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
0.9 |
| mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
-0.0021 |
0.9 |
| mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.0022 |
0.9 |
| mRNA |
PDMP |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
0.9 |
| mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0021 |
0.9 |